Research - Page 150 of 720 Posts on Medivizor
Navigation Menu

Research Posts on Medivizor

Zanubrutinib treatment for relapsed or unresponsive small lymphocytic lymphoma

Zanubrutinib treatment for relapsed or unresponsive small lymphocytic lymphoma

Posted by on May 31, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study aimed to investigate the safety and effectiveness of zanubrutinib in patients with relapsed/unresponsive chronic lymphocytic leukemia and small lymphocytic lymphoma. This study concluded that zanubrutinib was well tolerated and with promising effectiveness in these patients.    Some background Bruton tyrosine...

Read More

Risks of developing kidney toxicity in patients with multiple myeloma treated by carfilzomib

Risks of developing kidney toxicity in patients with multiple myeloma treated by carfilzomib

Posted by on May 31, 2020 in Multiple Myeloma | 0 comments

In a nutshell The study analyzed multiple clinical trials for assessing the effects of carfilzomib (Kyprolis) based treatment on kidney toxicity in patients with multiple myeloma (MM). The main finding was that kidney toxicity was an important side effect of carfilzomib based therapy. Some background Carfilzomib is largely used to treat MM. It is a...

Read More

The occurrence of cardiac autonomic dysfunction in patients who survived childhood acute lymphoblastic leukemia

The occurrence of cardiac autonomic dysfunction in patients who survived childhood acute lymphoblastic leukemia

Posted by on May 31, 2020 in Leukemia | 0 comments

In a nutshell The study evaluated occurrence, risk-factor, and exercise response of cardiac autonomic dysfunction (CAD) in adult survivors of childhood acute lymphoblastic leukemia (ALL). The authors found that over one-third of survivors developed CAD. It was related to lower exercise capacity. Some background Survivors of childhood ALL have reduced...

Read More

Does glucose control influence outcomes for patients with COVID-19 and type 2 diabetes?

Does glucose control influence outcomes for patients with COVID-19 and type 2 diabetes?

Posted by on May 31, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study looked at the outcomes of patients with type 2 diabetes (T2D) who were diagnosed with COVID-19. It found that patients with well-controlled blood glucose had fewer medical interventions and notably better survival. Some background COVID-19 is a highly infectious coronavirus that emerged in the Hubei province of China in late...

Read More

Evaluating minimally invasive surgery for patients with rectal cancer

Evaluating minimally invasive surgery for patients with rectal cancer

Posted by on May 31, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of minimally invasive surgery in rectal cancer. Researchers suggested that less invasive surgery methods can result in better short-term outcomes in appropriately selected patients. Some background Colorectal cancer is the third most common cancer in the US. Rectal cancer comprises around 20% of...

Read More

Evaluating malnutrition in hospitalized elderly patients with Parkinson’s disease

Evaluating malnutrition in hospitalized elderly patients with Parkinson’s disease

Posted by on May 31, 2020 in Parkinson's Disease | 0 comments

In a nutshell This study investigated the effects of malnutrition in elderly patients with Parkinson's disease (PD). Researchers suggested that patients with more advanced PD are more likely to be malnourished. Some background PD is a chronic disease that affects the brain cells. These cells lose their ability to control body functions which...

Read More

Cytokine-induced killer cell immunotherapy after surgery improves the outcomes of advanced colorectal cancer

Cytokine-induced killer cell immunotherapy after surgery improves the outcomes of advanced colorectal cancer

Posted by on May 31, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of the combined treatment with cytokine-induced killer cell (CIKC) immunotherapy and chemotherapy after surgery in colorectal cancer. Researchers suggested that this therapy improves treatment outcomes in patients with colorectal cancer. Some background Colorectal cancer is one of the most common...

Read More

Which therapy is more effective at boosting radiotherapy effectiveness for patients with localized prostate cancer?

Which therapy is more effective at boosting radiotherapy effectiveness for patients with localized prostate cancer?

Posted by on May 30, 2020 in Prostate cancer | 0 comments

In a nutshell This study compared whether radiotherapy (RT) was more effective when combined with hormone therapy or brachytherapy (BT) for patients with localized prostate cancer (PC). The authors found that patients who received hormone therapy and RT survived for longer. Some background External beam radiotherapy (EBRT) focuses beams of...

Read More

How safe and effective is biological drug brentuximab vedotin combined with R-CHP chemotherapy for patients with non-Hodgkin lymphoma?

How safe and effective is biological drug brentuximab vedotin combined with R-CHP chemotherapy for patients with non-Hodgkin lymphoma?

Posted by on May 30, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined the effectiveness and safety of adding brentuximab vedotin (Adcetris) to R-CHP (rituximab, cyclophosphamide, doxorubicin, and prednisone) chemotherapy for patients with non-Hodgkin lymphoma (NHL). The authors concluded that the treatment was very effective and safe for patients. Some background Chemotherapy...

Read More